Nuvalent Inc (NUVL)
65.62
-0.86
(-1.29%)
USD |
NASDAQ |
May 31, 16:00
65.57
-0.05
(-0.08%)
After-Hours: 20:00
Nuvalent Cash and Short Term Investments (Quarterly): 691.84M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 691.84M |
| December 31, 2023 | 719.90M |
| September 30, 2023 | 413.26M |
| June 30, 2023 | 431.24M |
| March 31, 2023 | 450.46M |
| December 31, 2022 | 472.16M |
| September 30, 2022 | 240.06M |
| Date | Value |
|---|---|
| June 30, 2022 | 256.96M |
| March 31, 2022 | 272.73M |
| December 31, 2021 | 288.11M |
| September 30, 2021 | 302.43M |
| June 30, 2021 | 138.92M |
| March 31, 2021 | 14.40M |
| December 31, 2020 | 10.33M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
10.33M
Minimum
Dec 2020
719.90M
Maximum
Dec 2023
335.92M
Average
295.27M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Geron Corp | 443.05M |
| Verastem Inc | 110.12M |
| Karyopharm Therapeutics Inc | 148.58M |
| Syndax Pharmaceuticals Inc | 443.16M |
| Arvinas Inc | 1.169B |